Bruce F. Scharschmidt
- Molecular Biology top 5%
- Surgery top 2%
- Oncology top 2%
- Hepatology top 0.5%
- Epidemiology top 2%
- Co-authors
- Rebecca W. Van DykeNancy M. BlankenshipRobert K. OcknerJohn R. LakeJohn FitzJeanne G. WaggonerE B KeeffeP D Berk
- Topics
- Drug Transport and Resistance Mechanisms (34 papers)Neonatal Health and Biochemistry (23 papers)Liver Disease Diagnosis and Treatment (22 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Biological Chemistry
- Partner nations
- United StatesGermanySpain
In The Last Decade
Bruce F. Scharschmidt
113 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 140
- Molecular Biology 1.5k
- Surgery 1.3k
- Oncology 1.2k
- Hepatology 1.1k
- Epidemiology 1.1k
Countries citing papers authored by Bruce F. Scharschmidt
This map shows the geographic impact of Bruce F. Scharschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce F. Scharschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce F. Scharschmidt more than expected).
Fields of papers citing papers by Bruce F. Scharschmidt
This network shows the impact of papers produced by Bruce F. Scharschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce F. Scharschmidt. The network helps show where Bruce F. Scharschmidt may publish in the future.
Co-authorship network of co-authors of Bruce F. Scharschmidt
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce F. Scharschmidt. A scholar is included among the top collaborators of Bruce F. Scharschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce F. Scharschmidt. Bruce F. Scharschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 10 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 48 | |
| 6 | 4 | |
| 7 | 27 | |
| 8 | 21 | |
| 9 | 33 | |
| 10 | 29 | |
| 11 | 72 | |
| 12 | 57 | |
| 13 | 5 | |
| 14 | 15 | |
| 15 | 62 | |
| 16 | 42 | |
| 17 | 3 | |
| 18 | Measurement of mono conjugated di conjugated and unconjugated bilirubin ix alpha in normal and hyper bilirubinemic serum | 1 |
| 19 | 1 | |
| 20 | Studies of the kinetics of purified conjugated bilirubin-3H in the rat. | 14 |
About Bruce F. Scharschmidt
Bruce F. Scharschmidt is a scholar working on Clinical Biochemistry, Hepatology and Pediatrics, Perinatology and Child Health, having authored 116 papers that have together received 4.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (34 papers), Neonatal Health and Biochemistry (23 papers) and Liver Disease Diagnosis and Treatment (22 papers). The work is most often cited by research in Hepatology (1.1k citations), Clinical Biochemistry (420 citations) and Oncology (1.2k citations). Bruce F. Scharschmidt has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Rebecca W. Van Dyke, Nancy M. Blankenship, Robert K. Ockner, John R. Lake, John Fitz, Jeanne G. Waggoner, E B Keeffe, P D Berk, Emmet B. Keeffe and Eberhard L. Renner. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.